Article
Single-cell data-driven design of armed oncolytic virus to boost cooperative innate-adaptive immunity against cancer
13 Dec 2024
Abstract excerpt
Oncolytic viruses have been considered promising cancer immunotherapies. However, oncovirotherapy agents impart durable responses in only a subset of cancer patients. Thus, exploring the cellular and molecular mechanisms underlying the heterogeneous responses in patients can provide guidance to develop more effective oncolytic virus therapies. Single-cell RNA sequencing (scRNA-seq) analysis of tumors responsive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
